Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-281 · Research funding opportunity
Overview
Supports translational research on the emergence or worsening of mood and psychotic symptoms during the menopause transition. Studies should investigate neurobiological or behavioural mechanisms that could inform future treatments.
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next new-application deadline: 5 October 2026. Next renewal/resubmission/revision deadline, where permitted: 5 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2028. This is separate from the application deadline.